GASTRIC CANCER STAGE I

This adverse event was reported 1054 times

GASTRIC CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 44 0.0008
1 EFINACONAZOLE 1 0.0005
2 CEFADROXIL 1 0.0005
3 RANITIDINE 86 0.0004
4 BARICITINIB 1 0.0003
5 GLYCOPYRROLATE 1 0.0002
6 ETODOLAC 1 0.0002
7 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 1 0.0002
8 DASATINIB 1 0.0001
9 LUBIPROSTONE 1 0.0001
See all drugs enriched for association with GASTRIC CANCER STAGE I

GASTRIC CANCER STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chloride Channel Activator [EPC] 1 0.0001
1 Aluminum Complex [EPC] 1 0.0000
2 Provitamin D2 Compound [EPC] 1 0.0000
3 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
4 Aminosalicylate [EPC] 2 0.0000
5 Macrolide Antimicrobial [EPC] 1 0.0000
6 Proteasome Inhibitor [EPC] 2 0.0000
7 BCL-2 Inhibitor [EPC] 1 0.0000
8 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
9 Estrogen [EPC] 2 0.0000
See all drug classes enriched for association with GASTRIC CANCER STAGE I